BMA Biomedicals is a small biotech company located in the Basel area in northern Switzerland. Founded in 1989 by a group of immunologists, biochemists and biologists, its main area of activity is in the generation, manufacturing and marketing of antibodies. In 2005, BMA Biomedicals was acquired by Chemoforma Inc., a long-time business partner active in the production of immune-supportive food additives.
BMA's knowledge and expertise lies mainly in the application of antibodies in immunohistochemistry and enzyme immunoassays. Even though the products are manufactured and sold for in vitro research use only, the licensing of successful products to companies which are active in medical diagnostics is supported.
BMA Biomedicals has its own modern research and development facilities. It is ideally equipped for carrying out contractual research for scientific and industrial institutions. Our know-how lies in the production and derivatization of monoclonal and polyclonal antibodies, and their use in immunological techniques. BMA also acquires products which are in line with internal activities. These products may be in early development stages and are finally updated for manufacture by the company.
You can find specialties and unique products that have been produced exclusively by BMA Biomedicals, as well as routine products with extensive publication records.
BMA's product focus on the fields of:
- -infectious diseases
- -tumor related diseases
BMA Biomedicals sells its products to all countries worldwide. To learn more please refer to the distributors' section in the menu.